Lynn A. Tetrault - Jun 21, 2024 Form 4 Insider Report for RHYTHM PHARMACEUTICALS, INC. (RYTM)

Role
Director
Signature
/s/ Hunter Smith, attorney-in-fact for Lynn A. Tetrault
Stock symbol
RYTM
Transactions as of
Jun 21, 2024
Transactions value $
$0
Form type
4
Date filed
6/25/2024, 04:38 PM
Previous filing
Jun 20, 2024
Next filing
Aug 13, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RYTM Common Stock Options Exercise +3K 3K Jun 21, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RYTM Restricted Stock Units Options Exercise $0 -3K -100% $0.00* 0 Jun 21, 2024 Common Stock 3K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
F2 The restricted stock units fully vested on June 21, 2024. The restricted stock units have no expiration date.